Last reviewed · How we verify
VAXIGRIP Prefilled Syringe INJ.
VAXIGRIP Prefilled Syringe INJ. is a vaccine that stimulates the body's immune system to produce antibodies against influenza.
VAXIGRIP Prefilled Syringe INJ. is a vaccine that stimulates the body's immune system to produce antibodies against influenza. Used for Prevention of influenza.
At a glance
| Generic name | VAXIGRIP Prefilled Syringe INJ. |
|---|---|
| Sponsor | Il-Yang Pharm. Co., Ltd. |
| Drug class | vaccine |
| Modality | Biologic |
| Therapeutic area | Infectious Disease |
| Phase | Phase 3 |
Mechanism of action
It works by introducing a small, harmless piece of the influenza virus to the body, which triggers an immune response and helps the body recognize and fight the virus in the future.
Approved indications
- Prevention of influenza
Common side effects
- Pain, redness, or swelling at the injection site
- Fatigue
- Headache
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- VAXIGRIP Prefilled Syringe INJ. CI brief — competitive landscape report
- VAXIGRIP Prefilled Syringe INJ. updates RSS · CI watch RSS
- Il-Yang Pharm. Co., Ltd. portfolio CI